Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

Clinical validation of ONCOFLASH® package in planar somatostatin receptor scintigraphy.

PHILIPPE THUILLIER, David Bourhis, Philippe Robin, Philippe Chaumet-Riffaud, Nathalie Keromnes, Pierre-Yves Le Roux, Veronique Kerlan, Pierre Salaun and Ronan Abgral
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1636;
PHILIPPE THUILLIER
2Endocrinology, CHRU BREST, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Bourhis
1NUCLEAR MEDICINE, CHRU BREST, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Robin
1NUCLEAR MEDICINE, CHRU BREST, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Chaumet-Riffaud
3NUCLEAR MEDICINE, CHU KREMLIN BICETRE, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Keromnes
1NUCLEAR MEDICINE, CHRU BREST, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre-Yves Le Roux
1NUCLEAR MEDICINE, CHRU BREST, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronique Kerlan
2Endocrinology, CHRU BREST, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Salaun
1NUCLEAR MEDICINE, CHRU BREST, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronan Abgral
1NUCLEAR MEDICINE, CHRU BREST, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1636

Objectives The objective of this study was to evaluate Oncoflash® package to reduce the acquisition time of planar somatostatin receptor scintigraphy (SRS) images indicated before realization of SPECT according to EANM guidelines.

Methods 71 consecutive SRS acquisitions in 59 patients were prospectively performed between January and December 2013. Acquisitions were performed in dynamic modality with two 7min30 images. On the one hand, these were summed to create a 15min untreated image. On the other hand, one single 7min30 image was processed with Oncoflash® package (Siemens, Erlangen, Germany). Each set of images was reviewed by three nuclear medicine physicians, blindly and independently (two seniors, one junior). Acquisition quality (good or bad), global exam interpretation (positive, inconclusive or negative) and lesion with maximal grade of uptake according to Krenning’s scale were recorded. High discordance rate (negative versus positive; gap ≥ 2 grades of uptake) for the analysis of the two sets of images were evaluated. Inter-observer variability was assessed by Cohen’s Kappa index (k).

Results Bad image quality was evaluated for 19.7% (42/213) and 18.3% (39/213) of untreated images and processed images with Oncoflash® package respectively (p=0.711). High discordance rate for global exam interpretation and lesion with maximal grade of uptake were 2.8% (6/213) and 1.4% (1/72) respectively. Inter-observer agreement study revealed k values between 0.51 and 0.61 for untreated images and between 0.56 and 0.62 for processed images with Oncoflash® package.

Conclusions Our results suggest the possibility of using the Oncoflash® module for the reconstruction of planar images of SRS allowing a reduction of acquisition time by a factor 2 without significant alteration of image quality or major impact on exam interpretation before performing SPECT acquisition.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical validation of ONCOFLASH® package in planar somatostatin receptor scintigraphy.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Clinical validation of ONCOFLASH® package in planar somatostatin receptor scintigraphy.
PHILIPPE THUILLIER, David Bourhis, Philippe Robin, Philippe Chaumet-Riffaud, Nathalie Keromnes, Pierre-Yves Le Roux, Veronique Kerlan, Pierre Salaun, Ronan Abgral
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1636;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical validation of ONCOFLASH® package in planar somatostatin receptor scintigraphy.
PHILIPPE THUILLIER, David Bourhis, Philippe Robin, Philippe Chaumet-Riffaud, Nathalie Keromnes, Pierre-Yves Le Roux, Veronique Kerlan, Pierre Salaun, Ronan Abgral
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1636;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • The Metabolic Superscan
  • FDG-PET/CT in the assessment of rheumatoid arthritis disease activity, complications, and treatment response
  • Evolution of the Gold Standard: Gastric Emptying scintigraphy beyond total gastric emptying.
Show more General Clinical Specialties

MTA II: Endocrinology/Neuroendocrine Posters

  • A PET study of burn-induced tissue-specific insulin resistance
  • Comparison of SPECT/CT, MIBI Planar and Ultrasonography in diagnosis of hyperparathyroidism.
  • Effects of hyperglycemia on FDG biodistribution in a large oncology clinical practice
Show more MTA II: Endocrinology/Neuroendocrine Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire